Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 27, 2022

Drug Sales Trends for ESOMEPRAZOLE

✉ Email this page to a colleague

« Back to Dashboard

Payment Methods and Pharmacy Types for ESOMEPRAZOLE (2019)

Revenues by Pharmacy Type

Chart
Table

Pharmacy Type	Revenues
INSIDE ANOTHER STORE	$4,596,331
INSIDE HMO/CLINIC/HOSPITAL	$4,543,660
[disabled in preview]	$123,261,335
This preview shows a limited data set Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Chart
Table

Pharmacy Type	Units
INSIDE ANOTHER STORE	3,474
INSIDE HMO/CLINIC/HOSPITAL	75,755
[disabled in preview]	139,743
This preview shows a limited data set Subscribe for full access, or try a Trial

Revenues by Payment Method

Chart
Table

Payment Method	Revenues
MEDICARE	$18,349,819
OTHER FEDERAL	$4,543,660
[disabled in preview]	$109,507,846
This preview shows a limited data set Subscribe for full access, or try a Trial

Drug Sales Revenue Trends for ESOMEPRAZOLE

Drug Units Sold Trends for ESOMEPRAZOLE

Annual Sales Revenues and Units Sold for ESOMEPRAZOLE

These sales figures are drawn from a US national survey of drug expenditures

Subscribe to access the full database, or Try it Free
Drug Name	Revenues (USD)	Units	Year
ESOMEPRAZOLE	See Plans and Pricing	See Plans and Pricing	2019
ESOMEPRAZOLE	See Plans and Pricing	See Plans and Pricing	2018
ESOMEPRAZOLE	See Plans and Pricing	See Plans and Pricing	2017
ESOMEPRAZOLE	See Plans and Pricing	See Plans and Pricing	2016
ESOMEPRAZOLE	See Plans and Pricing	See Plans and Pricing	2015
ESOMEPRAZOLE	See Plans and Pricing	See Plans and Pricing	2014
ESOMEPRAZOLE	See Plans and Pricing	See Plans and Pricing	2013
>Drug Name	>Revenues (USD)	>Units	>Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon

McKesson

Boehringer Ingelheim

Express Scripts

AstraZeneca

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.